We are live on ! Find out more
PHP

Parkman Healthcare Partners Portfolio holdings

AUM $970M
1-Year Est. Return 79.46%
This Fund
S&P 500
This Quarter Est. Return
+27%
1 Year Est. Return
+79.46%
3 Year Est. Return
+312.89%
5 Year Est. Return
+648.59%
10 Year Est. Return
–
AUM
$577M
AUM Growth
+$117M
Cap. Flow
+$70.8M
Cap. Flow %
12.28%
Top 10 Hldgs %
35.5%
Holding
108
New
25
Increased
54
Reduced
16
Closed
13

Top Buys

Rank Stock Value
1
COR icon
Cencora
COR
+$14.9M
2
BDX icon
Becton Dickinson
BDX
+$11.1M
3
DHR icon
Danaher
DHR
+$10.9M
4
IMGN
Immunogen Inc
IMGN
+$9.93M
5
PODD icon
Insulet
PODD
+$8.9M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$10.2M
2
SGEN
Seagen Inc. Common Stock
SGEN
+$10M
3
ELV icon
Elevance Health
ELV
+$9.95M
4
LLY icon
Eli Lilly
LLY
+$9.5M
5
IQV icon
IQVIA
IQV
+$9.08M

Sector Composition

Rank Sector Weight
1 Healthcare 98.94%
2 Industrials 0.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UTHR icon
1
United Therapeutics
UTHR
$23.1B
$27.1M 4.71%
122,978
+14,906
+14% +$3.3M
BSX icon
2
Boston Scientific
BSX
$71.5B
$25.6M 4.44%
473,105
+44,874
+10% +$2.34M
SDGR icon
3
Schrodinger
SDGR
$1.36B
$24.1M 4.18%
482,626
+83,456
+21% +$2.82M
BDX icon
4
Becton Dickinson
BDX
$48.2B
$22.1M 3.83%
83,646
+43,858
+110% +$11.1M
THC icon
5
Tenet Healthcare
THC
$21.1B
$20.7M 3.58%
254,037
+68,205
+37% +$4.86M
LNTH icon
6
Lantheus
LNTH
$6.59B
$20.6M 3.57%
245,547
+58,360
+31% +$5.24M
PODD icon
7
Insulet
PODD
$9.79B
$16.7M 2.9%
58,051
+29,307
+102% +$8.9M
COR icon
8
Cencora
COR
$61.2B
$16.6M 2.88%
+86,250
New +$14.9M
IMGN
9
DELISTED
Immunogen Inc
IMGN
$15.9M 2.75%
+840,811
New +$9.93M
COO icon
10
Cooper Companies
COO
$14.5B
$15.4M 2.67%
160,492
-49,044
-23% -$4.6M
DHR icon
11
Danaher
DHR
$144B
$14.6M 2.53%
68,465
+51,301
+299% +$10.9M
RXST icon
12
RxSight
RXST
$260M
$14.4M 2.49%
498,631
+70,838
+17% +$1.58M
NBIX icon
13
Neurocrine Biosciences
NBIX
$16.6B
$13.2M 2.28%
139,735
-78,103
-36% -$7.63M
PCVX icon
14
Vaxcyte
PCVX
$8.64B
$11.4M 1.98%
228,505
+42,408
+23% +$2.01M
KROS icon
15
Keros Therapeutics
KROS
$221M
$11.1M 1.93%
276,815
+97,525
+54% +$4.28M
DXCM icon
16
DexCom
DXCM
$32B
$10.9M 1.9%
85,126
+6,199
+8% +$750K
WAT icon
17
Waters Corp
WAT
$39.9B
$10.8M 1.88%
40,688
+28,821
+243% +$8.02M
KRTX
18
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$10.7M 1.85%
49,233
+9,926
+25% +$2.13M
SILK
19
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
$9.99M 1.73%
307,525
+67,661
+28% +$2.47M
HAE icon
20
Haemonetics
HAE
$4B
$9.8M 1.7%
115,061
-25,679
-18% -$2.17M
ANIP icon
21
ANI Pharmaceuticals
ANIP
$1.78B
$9.39M 1.63%
174,477
+74,477
+74% +$3.3M
VRNA
22
DELISTED
Verona Pharma
VRNA
$8.48M 1.47%
400,987
-87,008
-18% -$1.86M
XENE icon
23
Xenon Pharmaceuticals
XENE
$6.12B
$8.38M 1.45%
217,740
-59,543
-21% -$2.37M
DCPH
24
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$8.07M 1.4%
573,239
+81,467
+17% +$1.17M
MNKD icon
25
MannKind Corp
MNKD
$1.32B
$7.39M 1.28%
1,816,581
+342,483
+23% +$1.43M
1
2 3 4 5

Similar funds

LOIM
Liberty One Investment Management Libertyville, Illinois $970M AUM 12.15% 1-Year Est. Return
SFO
Stokes Family Office New Orleans, Louisiana $969M AUM 19.6% 1-Year Est. Return
MGCM
Mane Global Capital Management New York $971M AUM 58.5% 1-Year Est. Return
JWM
Jackson Wealth Management Lake Mary, Florida $972M AUM 22.58% 1-Year Est. Return
WAM
WNY Asset Management Williamsville, New York $967M AUM
GHC
Graham Holdings Company Arlington, Virginia $967M AUM 15.12% 1-Year Est. Return
SAM
Stansberry Asset Management Westlake, Texas $973M AUM 21.39% 1-Year Est. Return
TCCM
Two Creeks Capital Management New York $974M AUM 2.54% 1-Year Est. Return

Parkman Healthcare Partners's Q2 2023 Portfolio in Review

As of Q2 2023, Parkman Healthcare Partners held 108 positions worth $577M, up 25% from $460M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parkman Healthcare Partners deployed $70.8M of net new capital in Q2 2023, opening 25 new positions and adding to 54 existing holdings. Its largest new stake was Cencora: 86,250 shares worth $16.6M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, down from 100% a quarter earlier, followed by Industrials.

On the sell side, the largest reduction was Shockwave Medical, Inc. Common Stock, an estimated $10.2M trimmed.

  • Parkman Healthcare Partners's largest Q2 2023 buy was Cencora: 86,250 shares worth $16.6M.
  • Parkman Healthcare Partners added most to Becton Dickinson in Q2 2023, an estimated $11.1M increase.
  • Parkman Healthcare Partners's biggest Q2 2023 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $10.2M.
  • Parkman Healthcare Partners fully exited Elevance Health in Q2 2023, selling an estimated $9.95M.
  • Parkman Healthcare Partners's ten largest holdings make up 35% of its $577M portfolio in Q2 2023.
  • Parkman Healthcare Partners opened 25 new positions and closed 13 in Q2 2023.
  • Parkman Healthcare Partners's portfolio value rose 25% quarter-over-quarter to $577M.

Based on Parkman Healthcare Partners's 13F filing for Q2 2023, filed 11 Aug 2023.